Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer

Aromatase is an enzyme that catalyzes the final step in the conversion of androgen to estrogen. It has become an attractive target for the treatment of estrogen responsive breast cancer. The study has been focused on designing aromatase inhibitors (AIs) that can be selected as probable drug candidat...

Full description

Saved in:
Bibliographic Details
Published inJournal of computational chemistry Vol. 31; no. 12; pp. 2342 - 2353
Main Authors Nagar, Shuchi, Saha, Achintya
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2010
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aromatase is an enzyme that catalyzes the final step in the conversion of androgen to estrogen. It has become an attractive target for the treatment of estrogen responsive breast cancer. The study has been focused on designing aromatase inhibitors (AIs) that can be selected as probable drug candidate for the treatment of breast cancer. In the present study, long chain diarylalkyl-imidazole and -triazole scaffolds have been considered for exploring pharmacophores as potent AIs using QSAR (Quantitative SAR) and pharmacophore mapping studies. The model generated in linear free energy QSAR study (R² = 0.905, Q²= 0.885, R² pred₍ts₎ = 0.763) showed the importance of hydrophobicity, size and shape of the molecule, van der Waals surface and hydrogen atom contribution influence the activity. 3D QSAR of comparative molecular field analysis (CoMFA, R²= 0.921, Q² = 0.741, R² pred₍ts₎= 0.583) showed that steric and electrostatic features along with hydrophobicity and electronic charge contribution at C₄ (Fig. 1) influence on the inhibitory activity. Comparative molecular similarity analysis (CoMSIA, R² = 0.874, Q² = 0.716, R² pred₍ts₎ = 0.591) study adjudged the presence of steric, electrostatic and hydrophobic fields together with hydrogen bond (HB) donor and acceptor play significant role in inhibitory activity to aromatase enzyme. Further pharmacophore mapping study (Q² = 0.947, Δcost = 113.171, R² pred₍ts₎ = 0.857) suggested that presence of HB acceptor, hydrophobicity with aromatic ring, and the importance of steric contribution influence on the activity. The critical distances among the features are also important for the inhibitor activity.
Bibliography:http://dx.doi.org/10.1002/jcc.21528
DST FAST track, University TEQIP schemes
Presented in International conference on Current Trends in Drug Design and Discovery, Lucknow (India), February 17-21, 2010.
istex:B87D6E7C4C21A0B3C7B3C2748B016B9BEF8FE5EE
ArticleID:JCC21528
ark:/67375/WNG-NHFW9X6T-D
Presented in International conference on Current Trends in Drug Design and Discovery, Lucknow (India), February 17‐21, 2010.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0192-8651
1096-987X
DOI:10.1002/jcc.21528